设在巴塞罗那的INBRIAIN神经电子公司为BCI技术筹集50M系列B,针对神经治疗。 Barcelona-based INBRAIN Neuroelectronics raises $50M Series B for BCI technology, targeting neurological treatments.
设在巴塞罗那的一家公司INBRAIN Neuro电子公司筹集了5 000万美元的B系列资金,以加强其基于石墨的脑计算机接口技术。 INBRAIN Neuroelectronics, a Barcelona-based firm, has raised $50 million in Series B funding to enhance its graphene-based brain-computer interface (BCI) technology. 在MEME.xpand的带领和现有投资者的支持下,资金将加速临床试验和团队扩张。 Led by imec.xpand and supported by existing investors, the funding will accelerate clinical trials and team expansion. INBRAIN的BCI旨在为神经疾病提供个性化治疗。 INBRAIN's BCI aims to provide personalized treatments for neurological conditions. 该公司最近开始在英国进行人类试验,以评估脑癌病人的装置安全性。 The company recently began human trials in the UK to evaluate device safety for brain cancer patients.